Immune cell quantitation in normal breast tissue lobules with and without lobulitis

Breast Cancer Research and Treatment

Volumn 144, Issue 3, 2014, Pages 539-549

  Degnim, Amy C ^a   Brahmbhatt, Rushin D ^a   Radisky, Derek C ^b   Hoskin, Tanya L ^a   Stallings Mann, Melody ^b   Laudenschlager, Mark ^a   Mansfield, Aaron ^a   Frost, Marlene H ^a   Murphy, Linda ^a   Knutson, Keith ^c   Visscher, Daniel W ^a  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC   (United States)

^c MAYO GRADUATE SCHOOL   (United States)

Author keywords

Breast lobules; Cancer immunosuppression; Immune cell; Lobulitis; Mucosal immunity

Indexed keywords

CD20 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; GLYCOPROTEIN P 15095;

ADAPTIVE IMMUNITY; ADULT; ARTICLE; BONE MARROW CELL; BREAST; CELL COUNT; CELL DENSITY; CELL INFILTRATION; CELLULAR DISTRIBUTION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DESCRIPTIVE RESEARCH; FEMALE; HELPER CELL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENT CELL; LEUKOCYTE; LOBULITIS; LYMPHOID CELL; MACROPHAGE; MASTITIS; MICROENVIRONMENT; MOLECULAR IMAGING; MONOCYTE; PRIORITY JOURNAL; STROMA CELL;

ADULT; ANTIGENS, CD; BREAST; BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNITY, MUCOSAL; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; INFLAMMATION; LYMPHOCYTES; LYMPHOCYTES, TUMOR-INFILTRATING; MIDDLE AGED; TUMOR MICROENVIRONMENT; YOUNG ADULT;

EID: 84899482563     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-014-2896-8     Document Type: Article

References (57)

1. Ghajar CM (2012) On leukocytes in mammary development and cancer. Cold Spring Harbor Perspect Biol. doi:10.1101/cshperspect.a013276
2. Ghajar CM, Bissell MJ (2008) Extracellular matrix control of mammary gland morphogenesis and tumorigenesis: insights from imaging. Histochem Cell Biol 130(6):1105-1118. doi:10.1007/s00418-008-0537-1
3. Reed JR, Schwertfeger KL (2010) Immune cell location and function during post-natal mammary gland development. J Mammary Gland Biol Neoplasia 15(3):329-339. doi:10.1007/s10911-010-9188-7
4. Brandtzaeg P (2010) The mucosal immune system and its integration with the mammary glands. J Pediatr 156(2 Suppl):S8-S15. doi:10.1016/j.jpeds.2009.11. 014
5. Goldman AS (1993) The immune system of human milk: antimicrobial, antiinflammatory and immunomodulating properties. Pediatr Infect Dis J 12(8):664-671
6. Spencer JP (2008) Management of mastitis in breastfeeding women. Am Fam Physician 78(6):727-731
7. O'Brien J, Martinson H, Durand-Rougely C, Schedin P (2012) Macrophages are crucial for epithelial cell death and adipocyte repopulation during mammary gland involution. Development 139(2):269-275. doi:10.1242/dev.071696
8. Ramirez RA, Lee A, Schedin P, Russell JS, Masso-Welch PA (2012) Alterations in mast cell frequency and relationship to angiogenesis in the rat mammary gland during windows of physiologic tissue remodeling. Dev Dyn 241(5):890-900. doi:10.1002/dvdy.23778
9. DeNardo DG, Barreto JB, Andreu P, Vasquez L, Tawfik D, Kolhatkar N, Coussens LM (2009) CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages. Cancer Cell 16(2):91-102. doi:10.1016/j.ccr.2009.06.018
10. Bingle L, Lewis CE, Corke KP, Reed MW, Brown NJ (2006) Macrophages promote angiogenesis in human breast tumour spheroids in vivo. Br J Cancer 94(1):101-107. doi:10.1038/sj.bjc.6602901 (Pubitemid 43088548)
11. DeNardo DG, Brennan DJ, Rexhepaj E, Ruffell B, Shiao SL, Madden SF, Gallagher WM, Wadhwani N, Keil SD, Junaid SA, Rugo HS, Hwang ES, Jirstrom K, West BL, Coussens LM (2011) Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy. Cancer Discov 1(1):54-67. doi:10.1158/2159-8274.CD-10-0028
12. Cardiff RD, Wellings SR (1999) The comparative pathology of human and mouse mammary glands. J Mammary Gland Biol Neoplasia 4(1):105-122
13. Macpherson AJ, Harris NL (2004) Interactions between commensal intestinal bacteria and the immune system. Nat Rev Immunol 4(6):478-485. doi:10.1038/nri1373 (Pubitemid 38745559)
14. Moore WE, Moore LH (1995) Intestinal floras of populations that have a high risk of colon cancer. Appl Environ Microbiol 61(9):3202-3207
15. Rogers AB (2011) Distance burning: how gut microbes promote extraintestinal cancers. Gut Microbes 2(1):52-57. doi:10.4161/gmic.2.1.14761
16. Hunt KM, Foster JA, Forney LJ, Schutte UM, Beck DL, Abdo Z, Fox LK, Williams JE, McGuire MK, McGuire MA (2011) Characterization of the diversity and temporal stability of bacterial communities in human milk. PLoS One 6(6):e21313. doi:10.1371/journal.pone.0021313
17. Arroyo R, Martin V, Maldonado A, Jimenez E, Fernandez L, Rodriguez JM (2010) Treatment of infectious mastitis during lactation: antibiotics versus oral administration of Lactobacilli isolated from breast milk. Clin Infect Dis 50(12):1551-1558. doi:10.1086/652763
18. Hartmann LC, Sellers TA, Frost MH, Lingle WL, Degnim AC, Ghosh K, Vierkant RA, Maloney SD, Pankratz VS, Hillman DW, Suman VJ, Johnson J, Blake C, Tlsty T, Vachon CM, Melton LJ III, Visscher DW (2005) Benign breast disease and the risk of breast cancer. N Engl J Med 353(3):229-237. doi:10.1056/NEJMoa044383 (Pubitemid 41058322)
19. Visscher DW, Pankratz VS, Santisteban M, Reynolds C, Ristimaki A, Vierkant RA, Lingle WL, Frost MH, Hartmann LC (2008) Association between cyclooxygenase-2 expression in atypical hyperplasia and risk of breast cancer. J Natl Cancer Inst 100(6):421-427. doi:10.1093/jnci/djn036 (Pubitemid 351480513)
20. Milanese TR, Hartmann LC, Sellers TA, Frost MH, Vierkant RA, Maloney SD, Pankratz VS, Degnim AC, Vachon CM, Reynolds CA, Thompson RA, Melton LJ III, Goode EL, Visscher DW (2006) Age-related lobular involution and risk of breast cancer. J Natl Cancer Inst 98(22):1600-1607 (Pubitemid 44811643)
21. McKian KP, Reynolds CA, Visscher DW, Nassar A, Radisky DC, Vierkant RA, Degnim AC, Boughey JC, Ghosh K, Anderson SS, Minot D, Caudill JL, Vachon CM, Frost MH, Pankratz VS, Hartmann LC (2009) Novel breast tissue feature strongly associated with risk of breast cancer. J Clin Oncol 27(35):5893-5898. doi:10.1200/JCO.2008.21.5079
22. Degnim AC, Visscher DW, Hoskin TL, Frost MH, Vierkant RA, Vachon CM, Shane Pankratz V, Radisky DC, Hartmann LC (2012) Histologic findings in normal breast tissues: comparison to reduction mammaplasty and benign breast disease tissues. Breast Cancer Res Treat 133(1):169-177. doi:10.1007/s10549-011-1746-1
23. Susan G (2013) Komen for the Cure Tissue Bank at the IU SImon Cancer Center in Indianapolis http://komentissuebank.iu.edu/. Accessed 18 Sept 2013
24. Watson CJ (2006) Post-lactational mammary gland regression: molecular basis and implications for breast cancer. Exp Rev Mol Med 8(32):1-15. doi:10.1017/S1462399406000196
25. Watson CJ, Kreuzaler PA (2011) Remodeling mechanisms of the mammary gland during involution. Int J Dev Biol 55(7-9):757-762. doi:10.1387/ijdb.113414cw
26. Valdez R, Thorson J, Finn WG, Schnitzer B, Kleer CG (2003) Lymphocytic mastitis and diabetic mastopathy: a molecular, immunophenotypic, and clinicopathologic evaluation of 11 cases. Mod Pathol 16(3):223-228. doi:10.1097/01.MP.0000056627.21128.74 (Pubitemid 36337428)
27. Haj M, Weiss M, Herskovits T (2004) Diabetic sclerosing lymphocytic lobulitis of the breast. J Diabetes Complic 18(3):187-191. doi:10.1016/S1056- 8727(03)00034-5 (Pubitemid 38622550)
28. Radisky DC, Santisteban M, Berman HK, Gauthier ML, Frost MH, Reynolds CA, Vierkant RA, Pankratz VS, Visscher DW, Tlsty TD, Hartmann LC (2011) p16(INK4a) expression and breast cancer risk in women with atypical hyperplasia. Cancer Prev Res (Phila) 4(12):1953-1960. doi:10.1158/1940-6207.CAPR-11-0282
29. Smyth MJ, Godfrey DI, Trapani JA (2001) A fresh look at tumor immunosurveillance and immunotherapy. Nat Immunol 4:293-299. doi:10.1038/86297 (Pubitemid 33706339)
30. Dunn GP, Old LJ, Schreiber RD (2004) The immunobiology of cancer immunosurveillance and immunoediting. Immunity 21(2):137-148. doi:10.1016/j.immuni.2004.07.017 (Pubitemid 39094044)
31. Schieferdecker HL, Ullrich R, Hirseland H, Zeitz M (1992) T cell differentiation antigens on lymphocytes in the human intestinal lamina propria. J Immunol 149(8):2816-2822
32. Zeitz M, Schieferdecker HL, Ullrich R, Jahn HU, James SP, Riecken EO (1991) Phenotype and function of lamina propria T lymphocytes. Immunol Resusc 10(3-4):199-206
33. Blumberg RS, Yockey CE, Gross GG, Ebert EC, Balk SP (1993) Human intestinal intraepithelial lymphocytes are derived from a limited number of T cell clones that utilize multiple V beta T cell receptor genes. J Immunol 150(11):5144-5153 (Pubitemid 23150382)
34. Regnault A, Kourilsky P, Cumano A (1995) The TCR-beta chain repertoire of gut-derived T lymphocytes. Semin Immunol 7(5):307-319
35. Montufar-Solis D, Garza T, Klein JR (2007) T-cell activation in the intestinal mucosa. Immunol Rev 215:189-201. doi:10.1111/j.1600-065X.2006.00471.x (Pubitemid 46212240)
36. Leishman AJ, Gapin L, Capone M, Palmer E, MacDonald HR, Kronenberg M, Cheroutre H (2002) Precursors of functional MHC class I- or class II-restricted CD8alphaalpha(+) T cells are positively selected in the thymus by agonist self-peptides. Immunity 16(3):355-364 (Pubitemid 34260914)
37. Rocha B, Vassalli P, Guy-Grand D (1991) The V beta repertoire of mouse gut homodimeric alpha CD8+ intraepithelial T cell receptor alpha/beta+ lymphocytes reveals a major extrathymic pathway of T cell differentiation. J Exp Med 173(2):483-486
38. Beagley KW, Fujihashi K, Lagoo AS, Lagoo-Deenadaylan S, Black CA, Murray AM, Sharmanov AT, Yamamoto M, McGhee JR, Elson CO et al (1995) Differences in intraepithelial lymphocyte T cell subsets isolated from murine small versus large intestine. J Immunol 154(11):5611-5619
39. Kunkel EJ, Butcher EC (2003) Plasma-cell homing. Nat Rev Immunol 3(10):822-829. doi:10.1038/nri1203 (Pubitemid 37328660)
40. Cebra JJ (1999) Influences of microbiota on intestinal immune system development. Am J Clin Nutr 69(5):1046S-1051S
41. Taylor BC, Dellinger JD, Cullor JS, Stott JL (1994) Bovine milk lymphocytes display the phenotype of memory T cells and are predominantly CD8+. Cell Immunol 156(1):245-253. doi:10.1006/cimm 1994.1169
42. Zitvogel L, Tesniere A, Kroemer G (2006) Cancer despite immunosurveillance: immunoselection and immunosubversion. Nat Rev Immunol 6(10):715-727. doi:10.1038/nri1936 (Pubitemid 44453458)
43. Ehrlich P (1909) Beiträge zur experimentellen Pathologie und Chemotherapie. Akademische Verlagsgesellschaft, Leipzig
44. Zahl PH, Andersen JM, Maehlen J (2004) Spontaneous regression of cancerous tumors detected by mammography screening. JAMA J Am Med Assoc 292(21):2579-2580. doi:10.1001/jama.292.21.2579 (author reply 2580)
45. Lee AH, Gillett CE, Ryder K, Fentiman IS, Miles DW, Millis RR (2006) Different patterns of inflammation and prognosis in invasive carcinoma of the breast. Histopathology 48(6):692-701. doi:10.1111/j.1365-2559.2006.02410.x
46. Aaltomaa S, Lipponen P, Eskelinen M, Kosma VM, Marin S, Alhava E, Syrjanen K (1992) Lymphocyte infiltrates as a prognostic variable in female breast cancer. Eur J Cancer 28A(4-5):859-864
47. Matkowski R, Gisterek I, Halon A, Lacko A, Szewczyk K, Staszek U, Pudelko M, Szynglarewicz B, Szelachowska J, Zolnierek A, Kornafel J (2009) The prognostic role of tumor-infiltrating CD4 and CD8 T lymphocytes in breast cancer. Anticancer Res 29(7):2445-2451
48. Giorno R (1983) Mononuclear cells in malignant and benign human breast tissue. Arch Pathol Lab Med 107(8):415-417
49. Lwin KY, Zuccarini O, Sloane JP, Beverley PC (1985) An immunohistological study of leukocyte localization in benign and malignant breast tissue. Int J Cancer 36(4):433-438 (Pubitemid 16225641)
50. Ben-Hur H, Cohen O, Schneider D, Gurevich P, Halperin R, Bala U, Mozes M, Zusman I (2002) The role of lymphocytes and macrophages in human breast tumorigenesis: an immunohistochemical and morphometric study. Anticancer Res 22(2B):1231-1238 (Pubitemid 34836180)
51. Ruffell B, Au A, Rugo HS, Esserman LJ, Hwang ES, Coussens LM (2012) Leukocyte composition of human breast cancer. Proc Natl Acad Sci USA 109(8):2796-2801. doi:10.1073/pnas.1104303108
52. Krishnan K, Bassett JK, MacInnis RJ, English DR, Hopper JL, McLean C, Giles GG, Baglietto L (2013) Associations between weight in early adulthood, change in weight, and breast cancer risk in postmenopausal women. Cancer Epidemiol Biomarkers Prev 22(8):1409-1416. doi:10.1158/1055-9965.EPI-13-0136
53. Brisson J, Morrison AS, Kopans DB, Sadowsky NL, Kalisher L, Twaddle JA, Meyer JE, Henschke CI, Cole P (1984) Height and weight, mammographic features of breast tissue, and breast cancer risk. Am J Epidemiol 119(3):371-381 (Pubitemid 14154480)
54. Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, Mulvihill JJ (1989) Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 81(24):1879-1886 (Pubitemid 20026073)
55. Tyrer J, Duffy SW, Cuzick J (2004) A breast cancer prediction model incorporating familial and personal risk factors. Stat Med 23(7):1111-1130. doi:10.1002/sim.1668 (Pubitemid 38477070)
56. Hermsen BB, von Mensdorff-Pouilly S, Fabry HF, Winters HA, Kenemans P, Verheijen RH, van Diest PJ (2005) Lobulitis is a frequent finding in prophylactically removed breast tissue from women at hereditary high risk of breast cancer. J Pathol 206(2):220-223. doi:10.1002/path.1774 (Pubitemid 40754026)
57. Gulbahce HE, Vanderwerf S, Blair C, Sweeney C (2014) Lobulitis in nonneoplastic breast tissue from breast cancer patients: association with phenotypes that are common in hereditary breast cancer. Hum Pathol 45(1):78-84. doi:10.1016/j.humpath.2013.08.008